Does mCP-induced protein 1 mediate the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo?
Our in vitro and in vivo studies demonstrate that MCPIP1 is an important mediator of minocycline-induced protection from brain ischemia.
Accordingly, it is suggested that maternal hormone profiles may partially explain the unusual sex ratios (of probands and their sibs), as well as the malformations.